Preliminary results of a phase Ib study combining ABT-199 and obinutuzumab in CLL
Current and future CLL diagnostic tools
Importance of Bcl-2-targeted therapies
John Gribben et al.
Debate on the best first-line treatment for unmutated CLL: opinions from across the Atlantic
New CLL treatments, the standard of care and the importance of clonal evolution